The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.

While some would like to see practice change to dropping aspirin earlier, these decisions will likely depend on individual ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 ...

LONDON, England—For patients with high-risk atrial fibrillation (AF) and stable coronary artery disease, it makes sense to drop antiplatelet therapy and move forward with anticoagulation monotherapy, ...

The study commencement is based on previous clinical safety and efficacy data, along with robust preclinical evidence.

Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy.

ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

Scorpion Therapeutics, Inc. (“Scorpion”), a pioneering clinical-stage oncology company dedicated to transforming the lives of ...